AMC
AMC Entertainment Holdings, Inc.
AMC has the edge over TME overall, supported by stronger fundamentals and stronger modeled upside.
TME
Tencent Music Entertainment Group
TME has lower modeled downside risk, despite its lower overall score.
AMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Under pressure |
AMC's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is under pressure.
TME Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
TME's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
AMC PE Valuation
AMC has no meaningful PE right now: it lost money over the past year.
TME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 11x | $9.02 | — |
| Cheap | 12x | $9.60 | +6.4% |
| Fair | 32x | $26.45 | +193% |
| Expensive | 52x | $43.01 | +377% |
Historical ranges are pointers, not guarantees.
TME's PE is 11x, but its earnings don't support one, so it isn't a reliable read right now.
AMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
AMC has the edge over TME on the outlook, with more favorable profitability expectations.
TME Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for TME, with profitability holding steady.
AMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.40 | +$0.94 |
| Q2 2026 | -$1.10 | -$0.28 |
| Q1 2026 | -$1.09 | -$0.18 |
| Q4 2025 | -$1.34 | -$0.28 |
| Q3 2025 | -$1.34 | +$0.29 |
| Q2 2025 | -$0.82 | +$0.67 |
| Q1 2025 | -$0.91 | +$0.38 |
| Q4 2024 | -$1.06 | +$1.31 |
AMC lost $0.40 per share over the past year, a smaller loss than the year before.
TME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.83 | -16% |
| Q1 2026 | $0.82 | -11% |
| Q4 2025 | $1.04 | +63% |
| Q3 2025 | $1.05 | +81% |
| Q2 2025 | $0.99 | +83% |
| Q1 2025 | $0.92 | +84% |
| Q4 2024 | $0.64 | +36% |
| Q3 2024 | $0.58 | +29% |
TME has the edge over AMC on earnings quality, reporting a profit while its opponent remains loss making.
AMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +32% |
| Q2 2026 | $1.6B | +14% |
| Q1 2026 | $1B | +21% |
| Q4 2025 | $1.3B | -1.4% |
| Q3 2025 | $1.3B | -3.6% |
| Q2 2025 | $1.4B | +36% |
| Q1 2025 | $862.5M | -9.3% |
| Q4 2024 | $1.3B | +18% |
AMC's revenue is growing: $1.7B last quarter, up 32% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +12 points |
| Q2 2026 | 15% | +8.3 points |
| Q1 2026 | -4.4% | +13 points |
| Q4 2025 | 0% | -0.3 points |
| Q3 2025 | 2.8% | -2.6 points |
| Q2 2025 | 6.6% | +11 points |
| Q1 2025 | -17% | -5.5 points |
| Q4 2024 | 0.4% | +14 points |
AMC's operating margin was 15% last quarter, up 12 points from the same quarter a year ago, near the top of its range since 2019.
TME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.3B | +5.8% |
| Q1 2026 | $1.2B | +6.7% |
| Q4 2025 | $1.2B | +3.8% |
| Q3 2025 | $1.3B | +21% |
| Q2 2025 | $1.3B | +18% |
| Q1 2025 | $1.1B | +8.7% |
| Q4 2024 | $1.1B | +8.2% |
| Q3 2024 | $1.1B | +6.8% |
TME's revenue has grown year over year for eight quarters in a row: $1.3B last quarter, up 5.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -1.3 points |
| Q1 2026 | 30% | -36 points |
| Q4 2025 | 34% | +1.5 points |
| Q3 2025 | 32% | +1.5 points |
| Q2 2025 | 35% | +4.6 points |
| Q1 2025 | 66% | +37 points |
| Q4 2024 | 32% | +7.4 points |
| Q3 2024 | 31% | +8.9 points |
TME has the edge over AMC on profitability, with a higher operating margin.
AMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $109.3M | +$190.4M |
| Q2 2026 | $190.1M | +114% |
| Q1 2026 | -$174.7M | +$242.3M |
| Q4 2025 | $43.3M | -62% |
| Q3 2025 | -$81.1M | +$11.1M |
| Q2 2025 | $88.9M | +$168.1M |
| Q1 2025 | -$417M | -$178.2M |
| Q4 2024 | $113.9M | +$263.8M |
AMC has the edge over TME on cash flow, with more consistent year-over-year improvement.
TME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $429.8M | +75% |
| Q1 2026 | $350M | -7.4% |
| Q4 2025 | $0 | -100% |
| Q3 2025 | $552.7M | +70% |
| Q2 2025 | $245.8M | -44% |
| Q1 2025 | $378M | -6.2% |
| Q4 2024 | $324.3M | +19% |
| Q3 2024 | $324.9M | +50% |
TME's free cash flow has been positive every quarter for seven years: $1.3B over the past year, up 4.7% from the year before.
AMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +24% | +175M shares |
| 1 year | +107% | +463M shares |
| 3 years | +767% | +793M shares |
| 5 years | +4063% | +875M shares |
AMC has 897M diluted shares, up 107% from a year ago.
TME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +0.3% | +4.2M shares |
| 3 years | -1.8% | -28.7M shares |
| 5 years | -7.8% | -132M shares |
| Available history | -6.6% | -110M shares |
TME has the edge over AMC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $97.8M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $321.5M |
| Q3 2024 | — |
TME spent $98M buying back its own shares over the past year, down 70% from the year before.
AMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 9.2x | High |
| Q4 2025 | 12.2x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 10.7x | High |
| Q1 2025 | 18.6x | High |
| Q4 2024 | 14.3x | High |
AMC's net debt is about 4.0 years of its operating earnings (EBITDA), down from 12 years a year ago.
TME Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.9x | Net Cash |
| Q3 2024 | -0.6x | Net Cash |
TME has the edge over AMC on leverage, with a lower net debt burden relative to earnings.
AMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.3 | Neutral |
| Stochastic | 65.4 | Neutral |
AMC's weekly RSI is 67 (neutral) and its Stochastic is 65 (neutral).
TME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.0 | Neutral |
| Stochastic | 58.8 | Neutral |
TME's weekly RSI is 47 (neutral) and its Stochastic is 59 (neutral).
AMC PE vs Communication Services Sector
AMC has no meaningful PE right now: it lost money over the past year.
TME PE vs Communication Services Sector
| Metric | TME | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 16x | 34% below |
| PE % | 12 | 26 | 14 pts below |
TME is trading at 11x earnings, a 34% discount to the Communication Services sector's median of 16x, though its earnings don't support one.
AMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.01 | 11% above |
| 20 week MA | $2.64 | 27% above |
| 50 week MA | $2.01 | 66% above |
| 100 week MA | $2.53 | 32% above |
| 200 week MA | $10.9 | 69% below |
AMC has the edge over TME on trend strength, trading above more of its moving averages.
TME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.58 | 5.1% above |
| 20 week MA | $8.67 | 4% above |
| 50 week MA | $11.2 | 19% below |
| 100 week MA | $14.4 | 37% below |
| 200 week MA | $12.0 | 25% below |
TME has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 25% below its 200-week average.
AMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $12.6 | -66% |
| 2021 | $12.6 | $142.6 | +1036% |
| 2022 | $142.6 | $44.0 | -69% |
| 2023 | $44.0 | $6.12 | -86% |
| 2024 | $6.12 | $4.00 | -35% |
| 2025 | $4.00 | $1.69 | -58% |
| 2026 YTD | $1.69 | $3.34 | +98% |
AMC has the edge over TME on returns for 2026, with the stronger performance.
TME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.9 | $18.9 | +58% |
| 2021 | $18.9 | $6.50 | -66% |
| 2022 | $6.50 | $8.06 | +24% |
| 2023 | $8.06 | $9.01 | +12% |
| 2024 | $9.01 | $11.7 | +30% |
| 2025 | $11.7 | $17.6 | +50% |
| 2026 YTD | $17.6 | $9.02 | -49% |
TME is down 49% so far in 2026, after finishing higher in five of the previous six years.